CD8A and tuberculosis: An interesting study performed in Japan on active TB patients demonstrated a decline of the surrogate CD8+ T-cell response (difference “TB2 minus TB1”) at the end of treatment and suggested the use of QFT-Plus as a tool to help monitoring TB therapy efficacy36.